the Regulation of Tramadol Pain Relief Medication in Taiwan - Pharmacology

More Info

---

Tramadol, known as Tramal in some regions, is a medication classified as a Schedule IV controlled substance in many countries, including Taiwan. This classification indicates that while Tramadol has accepted medical uses, it also has the potential for abuse and dependence, albeit to a lesser extent than more potent opioids. In Taiwan, the regulation of Tramadol is governed by the Ministry of Health and Welfare, which oversees the prescription and distribution of controlled substances.

In response to your inquiry about the availability of Tramal cap 50mg (Tramadol) in Taiwan, it appears that specific hospitals may not stock this medication, as indicated in the previous responses. Instead, they may offer alternative formulations, such as Ultracet, which combines Tramadol with Acetaminophen. This combination can provide effective pain relief while potentially reducing the risk of dependence associated with higher doses of Tramadol alone.

Regarding the therapeutic effects of Tramadol, it is primarily indicated for the management of moderate to severe pain, both acute and chronic. It works by binding to the mu-opioid receptors in the brain and inhibiting the reuptake of norepinephrine and serotonin, which contributes to its analgesic properties. However, it is essential to note that long-term use of Tramadol can lead to the development of tolerance, meaning higher doses may be required over time to achieve the same pain-relieving effects. This tolerance can subsequently lead to physical and psychological dependence.

When considering the use of Tramadol in patients with compromised renal function, such as those with an estimated glomerular filtration rate (eGFR) of 20 or 30, caution is warranted. While Tramadol itself does not directly affect kidney function, its metabolism and clearance can be significantly altered in individuals with renal impairment. The drug is primarily metabolized in the liver, but its metabolites are excreted through the kidneys. Therefore, in patients with reduced renal function, the elimination of Tramadol and its active metabolites may be prolonged, increasing the risk of adverse effects such as sedation, dizziness, and nausea. For this reason, it is advisable to initiate treatment with a lower dose and closely monitor for any side effects.

In summary, Tramadol is a regulated medication in Taiwan, classified as a Schedule IV controlled substance due to its potential for abuse and dependence. It is effective for pain management but requires careful consideration in patients with renal impairment. If you are seeking Tramadol or similar medications, it is best to consult with a healthcare provider who can assess your specific medical needs and determine the most appropriate treatment plan. Always ensure that medications are obtained through legitimate channels to ensure safety and compliance with local regulations.